Given this, it is not surprising that there is considerable variation in the duration, severity, symptoms, age of onset and clinical/neuropathological correlations of AD. However, the fact that AD is a late-onset neurodegenerative disease with no accurate diagnostic markers makes the study and identification of the genetic, environmental and therapeutic factors that modify risk for AD exceedingly